Model
Edge
Regeneron Pharmaceuticals, Inc.
0001681643
Filing type
144
Filing date
Jan 1, 2024
Updated
Jan 2, 2024 ยท 9:06 AM
Copy reference
Filing
144
Notice of Proposed Sale of Securities